Canaccord Genuity Group Forecasts Strong Price Appreciation for Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group (NASDAQ:PRVA) had its target price boosted by Canaccord Genuity Group from $29.00 to $30.00 in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the stock.

A number of other analysts also recently weighed in on PRVA. Needham & Company LLC upped their target price on shares of Privia Health Group from $25.00 to $30.00 and gave the stock a “buy” rating in a research report on Friday. Truist Financial upped their price target on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Piper Sandler upped their price target on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an “overweight” rating in a research note on Friday. Macquarie began coverage on shares of Privia Health Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $25.00 price target on the stock. Finally, JMP Securities restated a “market outperform” rating and set a $26.00 target price on shares of Privia Health Group in a research note on Friday, February 14th. One investment analyst has rated the stock with a hold rating, fifteen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $26.59.

Privia Health Group Price Performance

NASDAQ:PRVA opened at $24.97 on Friday. The firm’s 50-day moving average price is $22.40 and its 200-day moving average price is $20.59. The company has a market capitalization of $3.00 billion, a PE ratio of 249.72, a P/E/G ratio of 3.47 and a beta of 0.87. Privia Health Group has a 1-year low of $15.92 and a 1-year high of $26.04.

Institutional Trading of Privia Health Group

Several institutional investors and hedge funds have recently made changes to their positions in the business. Quadrant Capital Group LLC lifted its position in shares of Privia Health Group by 11.8% during the fourth quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company’s stock worth $95,000 after purchasing an additional 511 shares during the last quarter. Park Avenue Securities LLC grew its stake in Privia Health Group by 3.8% in the fourth quarter. Park Avenue Securities LLC now owns 14,697 shares of the company’s stock valued at $287,000 after purchasing an additional 532 shares during the last quarter. PNC Financial Services Group Inc. grew its stake in shares of Privia Health Group by 8.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company’s stock worth $140,000 after acquiring an additional 533 shares during the last quarter. First Horizon Advisors Inc. grew its stake in shares of Privia Health Group by 53.8% during the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after acquiring an additional 632 shares during the last quarter. Finally, Summit Investment Advisors Inc. grew its stake in shares of Privia Health Group by 6.8% during the fourth quarter. Summit Investment Advisors Inc. now owns 10,673 shares of the company’s stock worth $209,000 after acquiring an additional 678 shares during the last quarter. 94.48% of the stock is currently owned by institutional investors.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.